SCHEMBL6156936

SCHEMBL6156936

CC(N)C(=O)C(c1c[nH]cn1)C(NI)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17627358 0.88
SCHEMBL667476 0.88
SCHEMBL27768915 0.87 AKR1B1 (0.30)
SCHEMBL28059879 0.87 AKR1B1 (0.30)
SCHEMBL679593 0.82 SLC7A5 (0.33)
SCHEMBL5283576 0.82 SLC7A5 (0.33)
SCHEMBL52161 0.82 SLC7A5 (0.33)
SCHEMBL719518 0.81 SLC7A5 (0.32)
SCHEMBL4939776 0.81 SLC7A5 (0.32)
SCHEMBL11170380 0.80 SMN1; SMN2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581177-B1 CUTANEOUS METABOLIC BIO-ACTIVATOR THOREL JEAN NOEL (FR) 2018-04-11 EP disclosed
US-20160015777-A1 Protein Delivery System and Method of Making Same Nutraceutical Strategies Corporation (US) 2016-01-21 US disclosed
EP-1581177-A2 CUTANEOUS METABOLIC BIO-ACTIVATOR Thorel, Jean-Noel (FR) 2005-10-05 EP disclosed
WO-2004060393-A2 CUTANEOUS METABOLIC BIO-ACTIVATOR THOREL JEAN-NOEL (FR) 2004-07-22 WO disclosed